Talon Metals Announces $4.1 Million Bought Deal Private PlacementMarketwired (press release)The Underwriters will also receive warrants (“Broker Warrants“) equal to 6.0% of the Units sold pursuant to the Offering. Each Broker Warrant will entitle the holder to acquire one Common Share at a price of $0.30 until the date that is 24 months from … […]
Così, Inc : Announces Record Date and Subscription Price for Planned Rights …StockhouseBOSTON, MA, October 23, 2014 – As previously announced, Così, Inc. (NASDAQ: COSI), the fast casual restaurant company, intends to pursue a rights offering for up to $20 million of its common stock, par value $0.01 per share. A record date of October
Celator(R) Pharmaceuticals Announces Pricing of a $12.9 Million Public …Virtual-Strategy Magazine (press release)The shares of common stock and warrants are being offered in units consisting of one share of common stock and a warrant to purchase 0.10 of a share of common stock at a price of $1.95 per unit. The gross proceeds to Celator
Celator Pharmaceuticals Announces Pricing Of A $12.9M Public Offering Of …BenzingaCelator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the pricing of an underwritten public offering of 6,611,150 shares of common stock and warrants to … and more …read more
Celator Pharmaceuticals Announces Pricing Of A $12.9M Public Offering Of … – Benzinga Read More »
Celator(R) Pharmaceuticals Announces Pricing of a $12.9 Million Public …NasdaqThe shares of common stock and warrants are being offered in units consisting of one share of common stock and a warrant to purchase 0.10 of a share of common stock at a price of $1.95 per unit. The gross proceeds to Celator from this offering
Celator(R) Pharmaceuticals Announces Pricing of a $12.9 Million Public … – Nasdaq Read More »
Celator(R) Pharmaceuticals Announces Pricing of a $12.9 Million Public …CNNMoneyThe shares of common stock and warrants are being offered in units consisting of one share of common stock and a warrant to purchase 0.10 of a share of common stock at a price of $1.95 per unit. The gross proceeds to Celator from this offering
Celator(R) Pharmaceuticals Announces Pricing of a $12.9 Million Public … – CNNMoney Read More »
Celator(R) Pharmaceuticals Announces Pricing of a $12.9 Million Public …MarketWatchCelator Pharmaceuticals, Inc. CPXX, -4.33% a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the pricing of an underwritten public offering of 6,611,150 shares of common stock and warrants to … and more …read more
Celator(R) Pharmaceuticals Announces Pricing of a $12.9 Million Public … – MarketWatch Read More »
Source: Brian Sylvester of The Gold Report (10/22/14) Graphite equities continue to trade sideways, but a handful are starting to emerge as best-in-class plays as they race to secure offtake agreements by derisking their projects through resource upgrading and economic studies. Ron Struthers, editor and publisher of Struthers’ Resource Stock Report,says that investors need to focus on companies
Focus on Graphite Companies with Green Energy and Technology Strategies Read More »
Transgenomic Announces $2.375 Million Private Placement FinancingPharmiWeb.com (press release)For each share of common stock purchased investors also received a warrant to purchase 0.5 shares of the Company’s common stock at an exercise price of $4.00 per share. The warrants have a term of exercise equal to five years from the first date of … and
Transgenomic Announces $2.375M Private Placement FinancingBenzingaFor each share of common stock purchased, investors also received a warrant to purchase 0.5 shares of the Company’s common stock at an exercise price of $4.00 per share. The warrants have a term of exercise equal to five years from the first date of … and more …read more
Transgenomic Announces $2.375M Private Placement Financing – Benzinga Read More »